Merck launches combo-pill for diabetes and high cholesterol


Under type 2 diabetes, the body either does not produce enough insulin or does not use insulin efficiently. In this condition, excess sugar, or glucose get accumulated in the blood and ultimately damages blood vessels and other organs.

A large number of people with diabetes also have high cholesterol, in general. Having both diabetes and high cholesterol, increases the risk of heart disease and stroke.

A person with diabetes, has at least twice as likely to have heart disease or a stroke.  CVD is a major complication of diabetes and the leading cause of early death among people with diabetes. About 65% of people with diabetes die from heart disease and stroke. People with type 2 diabetes also have high rates of blood pressure, lipid problems and obesity, which contribute to high rates of CVD. Both the diseases are to be treated separately.

Combined drug for both diabetes and high cholesterol
Merck & Co. (MRK) has launched a drug named Juvisync , a combined pill for type 2 diabetes and cholesterol with a combination of two of their drugs, already in the market...

i. e. glucose-lowering Januvia and and cholesterol-lowering Zocor.

It will reduce diabetes medication costs by combining two drugs for the price of one. Moreover, there will be six different dosage strengths available to accommodate the needs of the patients with different levels of cholesterol.

According to the American Diabetes Association, statin therapy for patients who have both diabetes and cardiovascular disease proves to be beneficial. This combination pill will  not only simplify medication, but also improve adherence to the treatment. Instead of taking a handful of different pills, patients who take Juvisync will need to take fewer pills, improving adherence.

The U.S. Food and Drug Administration (FDA) has approved Merck & Co. (MRK) Juvisync.


One Response

© 2012 Healthy Living. All rights reserved.
Proudly designed by Theme Junkie.